Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...

How AI and Big Data Are Revamping Clinical Trials Advances in artificial intelligence (AI) and Big Data are significantly ...

People with missing teeth may be able to grow new ones, say Japanese dentists testing a pioneering drug they hope will offer an alternative to dentures ...

In 2018 an investigation by the International Consortium of Investigative Journalists revealed that 83,000 deaths and over ...

A new study has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia.

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

Boundless Bio has decided against proceeding with testing of a treatment for solid tumors and colorectal cancer, and said that two of its top executives have decided to step down.

Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program, shares findings on ...

Tony Newberne is a high-risk myeloma survivor. He is also a CPT, dietary manager, and patient advocate for several nonprofits ...

Rochester General Hospital (RGH) is the first U.S. site of a groundbreaking pivotal clinical trial of the AquaPass, a system ...

More than 100 000 women older than 70 years are diagnosed with hormone receptor-positive, early-stage breast cancer each year in the USA.1 A large proportion are at low risk of disease recurrence, ...